Alluri Ram K, Yin Christine, Iorio Matthew L, Leland Hyuma, Wong Jason, Patel Ketan
University of Southern California, Los Angeles, USA.
Beth Israel Deaconess Medical Center, Boston, MA, USA.
Hand (N Y). 2017 Mar;12(2):127-134. doi: 10.1177/1558944716643080. Epub 2016 Jul 7.
The radiographic and clinical outcomes following vascularized bone grafting (VBG) for scaphoid nonunion have previously been reported in the literature; however, few studies report on patient-derived outcomes. The purpose of this study was to determine the effect of VBG for scaphoid nonunion on patient-derived outcomes. The MEDLINE and PubMed databases were queried for the use of VBG in scaphoid nonunion. We included studies that reported on patient-derived outcomes. We excluded studies with less than 10 patients or less than 6 months of follow-up. The primary outcomes assessed included functionality, percent and time to return to preinjury activity, postoperative pain, and patient satisfaction. Twenty-six articles described the outcomes of 520 patients with an average of 19.3 patients per study. Functionality was most commonly assessed by the Mayo Modified Wrist Score and Disabilities of the Arm, Shoulder and Hand scores, which improved by 53.1% and 81.7% postoperatively, respectively. Within 16 weeks, 90.3% of patients returned to their previous occupation or sporting activity. Pain was most commonly reported using a 0 to 10 visual analog scale and improved 4-fold postoperatively. Complete satisfaction was reported by 92% of patients. The most common complications were superficial infections (1.56%), neuropathic pain (1.56%), and complex regional pain syndrome (1.25%). VBG for scaphoid nonunion results in the improvement of patient-derived outcomes, and high rates of return to preinjury activity levels and patient satisfaction. Multiple metrics of patient-derived outcomes were utilized by the studies in our review without a clear consensus as to which metric is most responsive and accurate.
以往文献中曾报道过血管化骨移植(VBG)治疗舟骨不愈合后的影像学和临床结果;然而,很少有研究报道患者自身的预后情况。本研究的目的是确定VBG治疗舟骨不愈合对患者自身预后的影响。我们在MEDLINE和PubMed数据库中查询了VBG在舟骨不愈合治疗中的应用情况。我们纳入了报道患者自身预后情况的研究。我们排除了患者人数少于10例或随访时间少于6个月的研究。评估的主要预后指标包括功能、恢复到伤前活动水平的百分比和时间、术后疼痛以及患者满意度。26篇文章描述了520例患者的预后情况,每项研究平均有19.3例患者。功能最常通过梅奥改良腕关节评分和手臂、肩部和手部功能障碍评分进行评估,术后分别提高了53.1%和81.7%。在16周内,90.3%的患者恢复了之前的职业或体育活动。疼痛最常使用0至10的视觉模拟量表进行报告,术后改善了4倍。92%的患者表示完全满意。最常见的并发症是浅表感染(1.56%)、神经性疼痛(1.56%)和复杂性区域疼痛综合征(1.25%)。VBG治疗舟骨不愈合可改善患者自身的预后情况,并使恢复到伤前活动水平的比例和患者满意度较高。我们综述中的研究使用了多种患者自身预后指标,但对于哪种指标最敏感和准确尚无明确共识。